Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lerapolturev (PVSRIPO) + Pembrolizumab in Recurrent Glioblastoma
NCT04479241Phase 2Completed
- Sponsor
- Istari Oncology
- Start
- Oct 2020
- Primary completion
- Jun 2024
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lerapolturev in glioblastoma (GBM), sponsored by Istari Oncology. Started Oct 2020; status: completed.
02
Drugs
lerapolturev
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04479241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479241.